Pharmaceutical Technology

Discover how GSK, Boehringer Ingelheim, Takeda and more than 100 pharma leaders scale digital projects at AUTOMA+ 2026 in Switzerland.

Sandoz and Henlius will collaborate on up to 10 biosimilars amid opportunity to capitalise on global biosimilar loss-of-exclusivities.

Lantheus's radiodiagnostic is designed to identify cognitively impaired patients who have tau neurofibrillary tangle (NFT) pathology.

The EMA has validated the MAA from Pfizer and Valneva for their Lyme disease vaccine candidate, PF-07307405.

Phanes Therapeutics has received fast track designation from the US FDA for spevatamig to treat patients with advanced and metastatic BTC.

Khartis was co-founded two years ago by the team at XinThera, a biotech acquired by Gilead.

The FDA has granted accelerated approval to BMS' Zenbexus, along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma.

Xanadu Quantum Technologies and the University of Alberta in Canada partnered to advance algorithms to treat cancer.

Repligen's $1.5bn purchase of BioLife Solutions adds CryoStor biopreservation to its bioprocessing portfolio, underscoring pharma's shift toward integrated cell and gene therapy supply chains.

Recommended changes to the US immunisation schedule by President Trump have been met with widespread retaliation.